ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,271.78
0.05%
US Tech 100
22,358.40
0.49%
Dow Jones
44,231.92
-0.51%
Brent Oil
68.305
-0.43%
Bitcoin
116,519.43
-2.82%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Adaptive Biotechnologies Corporation (ADPT) Quote

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ADPT)

Adaptogenics Health Corp
11.265
-0.285
( -2.47% )
Updated: 11:37:01
15 min delayed - Upgrade to Realtime

Adaptive Biotechnologies Corporation (ADPT) Quote

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
11.265
( -2.47% )
Bid
11.37
Ask
11.27
Volume
358,341
11.18 Day's Range 11.62
3.845 52 Week Range 12.43
Market Cap
1.711B
Previous Close
11.55
Open
11.62
Last Trade
100
@
11.265
Last Trade Time
11:37:17
Financial Volume
$ 4,065,595
VWAP
11.3456
Average Volume (3m)
2,166,760
Shares Outstanding
151,916,722
Dividend Yield
-
PE Ratio
-10.79
Earnings Per Share (EPS)
-1.05
Revenue
178.96M
Net Profit
-159.49M

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.adaptivebiotech.com
Headquarters
Olympia, Washington, USA
Founded
-
Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $11.55. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 3.845 to $ 12.43.

Adaptive Biotechnologies currently has 151,916,722 shares outstanding. The market capitalization of Adaptive Biotechnologies is $1.75 billion. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -10.79.

Ask ADVFN Intelligence (AI)

ADPT Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 12 2025
ADPT (-2.47%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
May 14 2025
ADPT (-2.47%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
May 01 2025
ADPT (-2.47%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 01 2025
ADPT (-2.47%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.475-4.0459965928411.7412.35511.18183329711.87727843CS
41.0159.9024390243910.2512.4310.11261171911.56110087CS
124.36563.26086956526.912.436.9216676010.05605883CS
264.91577.40157480316.3512.436.25520558718.93249814CS
527.245180.2238805974.0212.433.84516339547.5010715CS
1561.75518.45425867519.5113.212.2813845526.58266882CS
260-32.265-74.121295658243.5371.252.28123805914.40318427CS

ADPT - Frequently Asked Questions (FAQ)

What is the current Adaptive Biotechnologies share price?
The current share price of Adaptive Biotechnologies is $ 11.265
How many Adaptive Biotechnologies shares are in issue?
Adaptive Biotechnologies has 151,916,722 shares in issue
What is the market cap of Adaptive Biotechnologies?
The market capitalisation of Adaptive Biotechnologies is USD 1.75B
What is the 1 year trading range for Adaptive Biotechnologies share price?
Adaptive Biotechnologies has traded in the range of $ 3.845 to $ 12.43 during the past year
What is the PE ratio of Adaptive Biotechnologies?
The price to earnings ratio of Adaptive Biotechnologies is -10.79
What is the cash to sales ratio of Adaptive Biotechnologies?
The cash to sales ratio of Adaptive Biotechnologies is 9.62
What is the reporting currency for Adaptive Biotechnologies?
Adaptive Biotechnologies reports financial results in USD
What is the latest annual turnover for Adaptive Biotechnologies?
The latest annual turnover of Adaptive Biotechnologies is USD 178.96M
What is the latest annual profit for Adaptive Biotechnologies?
The latest annual profit of Adaptive Biotechnologies is USD -159.49M
What is the registered address of Adaptive Biotechnologies?
The registered address for Adaptive Biotechnologies is 711 CAPITOL WAY S STE 204, UNITED STATES, OLYMPIA, WASHINGTON, 98501 1267
What is the Adaptive Biotechnologies website address?
The website address for Adaptive Biotechnologies is www.adaptivebiotech.com
Which industry sector does Adaptive Biotechnologies operate in?
Adaptive Biotechnologies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CYCCCyclacel Pharmaceuticals Inc
$ 12.60
(280.66%)
26.77M
XAGELongevity Health Holdings Inc
$ 5.56
(110.21%)
87.18M
ANPARich Sparkle Holdings Ltd
$ 4.86
(59.87%)
3.1M
PLRZPolyrizon Ltd
$ 1.0103
(48.12%)
98.37M
BLMZBloomZ Inc
$ 0.22305
(47.52%)
279.24M
SHOTWSafety Shot Inc
$ 0.0161
(-61.85%)
11.24k
RVYLRYVYL Inc
$ 0.3536
(-45.73%)
6.43M
RANIRani Therapeutics Holdings Inc
$ 0.4271
(-38.85%)
7.14M
WHLRLWheeler Real Estate Investment Trust Inc
$ 98.00
(-35.31%)
280
ABVEAbove Food Ingredients Inc
$ 1.615
(-34.88%)
9.25M
BLMZBloomZ Inc
$ 0.22305
(47.52%)
279.24M
IXHLIncannex Healthcare Ltd
$ 0.3029
(28.35%)
248.64M
NVDANVIDIA Corporation
$ 171.2788
(4.39%)
121.45M
MULNMullen Automotive Inc
$ 0.1119
(-4.85%)
113.65M
PLRZPolyrizon Ltd
$ 1.0103
(48.12%)
98.37M

Discussion

View Full Feed
vlispxpert vlispxpert 3 minutes ago
IRWD dip op
IRWD
Mr Smith 34 Mr Smith 34 3 minutes ago
Why doesn't the financial genius Park take some of that new share cash and pay down the outstanding
taxes on his international corporate headquarters at 510 Hamilton Street instead of incurring unnecessary additional expenses?
AND why aren't these covenant violations reported on any
SPZID
I-Glow I-Glow 4 minutes ago
Docsetc hasn't posted since 05/19/2025 - must be hard at work on the fake lawsuit.

IG
ENZC
28Rockets 28Rockets 4 minutes ago
There are many directions they can go with gtch, i heard a theory before probably here, they could use tokenize as a payment system for access to their many patents, software and products like magic2 or chip patents as a way of licensing.
Maybe CTO DANNY RITTMANS BUDDY MOTTI BECK AT NVIDIA O
GTCH
KngmAz KngmAz 4 minutes ago
Looking good - Don't miss out.
HGRAF
Investor2014 Investor2014 4 minutes ago
We can only hope I convinced a few others - someone as smart as yourself perhaps or is that too much to hope for.
AVXL
cojoboy cojoboy 4 minutes ago
Somehow, got 5.9 million to fill @ .0004..???smh...I'll take it..
CGAC
eliminate eliminate 4 minutes ago
It would appear
my little trap is no damned good to catch Moddy Dick
it needs Greenpeace and a Harpoon to take out the Japanese fishing fleet in the Beaufort Sea.
MULN
Redoocs Redoocs 5 minutes ago
I fully understand. I was just stating my opinion on shorting in general. None of my bets were/are ever against, only for. I just can't see betting against something.
But, that doesn't mean I can't criticize a team I've bet on.
I've still got my 2 at .58 holding with the hope it neve
NLST
Myth Myth 5 minutes ago
the chart guys must be happy as hell.....

doesn't get much better....
SHMN
NachoCheese47 NachoCheese47 5 minutes ago
.087. I was not expecting that today. Pleasant surprise. Spider thinking maybe hit .09 today? Had the popcorn out for sure. 
DTREF
ConstellationJoe ConstellationJoe 5 minutes ago
2,014,766 shares sold today. Odd for an expert market stock?
JAMN
budfoxfun budfoxfun 5 minutes ago
$ONAR News: ONAR CEO Claude Zdanow to Present at GenAi Week SV 2025 -
ONAR Holding Corporation
Thu, July 10, 2025 at 8:30 AM EDT

In This Article: ONAR
ONAR Holding Corporation

Miami, FL, July 10, 2025 (GLOBE NEWSWIRE) -- ONAR Holding Corporation (
ONAR
Spider-oo-Monkey Spider-oo-Monkey 6 minutes ago
somebody wake up oz ⏰
DTREF
train21 train21 6 minutes ago
$GTVH CHEAP SHARES YET
DONT MISS THE RUN UP COMING $$$$$
GTVH
misterfishman misterfishman 6 minutes ago
maybe its a sell on the news as usual in the otc.
GTCH
cadillacdave cadillacdave 7 minutes ago
What you are witnessing is "legal" market manipulation.

The hedge funds and institutions are capable of making large purchases and sales, which effectively move or suppress the share price. They play all sorts of games, buying and selling stocks between hedge funds etc.
IONQ
train21 train21 7 minutes ago
$GRLT LETS GO HERE TIME FOR THE BIG RUN UP

WAKE UP JOHHNNEY
HIRE SOMEBODY ALREADY GET THE SHARE PRICE UP
GRLT
I-Glow I-Glow 7 minutes ago
Too bad you don't understand Securities Law. As I made it perfectly clear.

IG
SRNW
waterchaser waterchaser 7 minutes ago
It’s fun living in pumper clowns heads 24/7.

It’s a hobby for me… seemingly life or death for IHUB gamblers.

The entertainment value here is priceless.
DJT
fink fink 8 minutes ago
Holding up nicely.

If I was a bet'n man, I'd have called a take down after 25%

Our BID is a .1325 AuD. Aussies are going to be pumped when they wake up. 30% or more,

But damn! Who would sell at this juncture?

Too much going on. Trump is
DTREF
jesster64 jesster64 8 minutes ago
" So which is it? Is the deal done or are they unprepared for approval and commercialization?"
If I may, deal may be contingent of approval, which would make sense because without approval, company has very little commercial value. Approval is everything which is why they submitted 1.7 millio
NWBO
BAR123 BAR123 8 minutes ago
Retail does not own 60% of the shares. Institutions own just under 43%, Insiders own approx 11% and if you add in the additional buy in from institutions over the last 3 months that have not been reported yet the institutions could be in the 50%- 60% range. That means retail would own 29%-39%. I
AVXL

Your Recent History

NASDAQ
ADPT
Adaptive Biotechnologies
Delayed Upgrade Clock
ADVFN
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads